Skip to main content
Clinical Trials/NCT05143710
NCT05143710
Completed
Not Applicable

The Features of Clinical Imaging, Disease Severity and Pregnancy Outcomes in Posterior Reversible Encephalopathy Syndrome With Preeclampsia or Eclampsia

Dunjin Chen1 site in 1 country354 target enrollmentOctober 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Posterior Reversible Encephalopathy Syndrome
Sponsor
Dunjin Chen
Enrollment
354
Locations
1
Primary Endpoint
biochemical parameters
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to determine the features of clinical imaging, disease severity and pregnancy outcomes in posterior reversible encephalopathy syndrome with preeclampsia or eclampsia.

Detailed Description

The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES with preeclampsia or eclampsia to analyze features of clinical imaging, disease severity and pregnancy outcomes during 2012 to 2021.Then, the investigators grouped all the patients into early onset group and late onset PE group according to gestational weeks to analyze differences of clinical imaging. Finally, the investigators grouped all the patients into good pregnancy outcomes group and poor pregnancy outcomes group according to diagnostic criteria, including the incidence of stillbirth and premature birth, to analyze differences of clinical imaging .

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
January 31, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Dunjin Chen
Responsible Party
Sponsor Investigator
Principal Investigator

Dunjin Chen

Director of obstetrics

Guangzhou Medical University

Eligibility Criteria

Inclusion Criteria

  • patients were diagnosed of PRES with PE or E
  • all patients provided written informed consent

Exclusion Criteria

  • patients combined with other neurological disorders
  • patients combined with mental illness

Outcomes

Primary Outcomes

biochemical parameters

Time Frame: Biochemical indicators were collected within 1 week of the hospital stay.

The PRES patients may have a lower level of serum albumin (﹤35g/L) ,and have a higher level of lactic dehydrogenase (﹥380U/L).

features of clinical imaging

Time Frame: Cranial Imaging was examined immediately at the onset of symptoms, such as s headaches, visual changes, seizures, consciousness impairment, mental disorders, and focal neurological deficits.

The imaging features were described by their location including frontal, parietal, occipital, temporal, cerebellum, basal ganglia, brain stem, deep white matter and callosum, and 1 point was recorded for each location involved.

blood pressure(BP)

Time Frame: The BP of patients was obtained immediately at the onset of symptoms.

hypertension:≥140/90mmHg

pregnancy outcomes

Time Frame: From day of admission until the day of discharge or date of death from any cause,whichever came first,assessed up to 1 year.

The PRES patients may have longer time of hospitalization.

Study Sites (1)

Loading locations...

Similar Trials